Dova Pharmaceuticals, a subsidiary of Swedish Orphan Biovitrum AB (Sobi)
Overview
Dova Pharmaceuticals is a subsidiary of Swedish Orphan Biovitrum AB (Sobi) focused on the development and commercialization of treatments for rare diseases. As part of Sobi, Dova Pharmaceuticals contributes to the company's mission of providing innovative therapies for those with rare conditions.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Dova Pharmaceuticals, a subsidiary of Swedish Orphan Biovitrum AB (Sobi) in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Dova Pharmaceuticals, a subsidiary of Swedish Orphan Biovitrum AB (Sobi)?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.